bibliographicCitation |
Deutsch E, Maggiorella L, Wen B, Bonnet ML, Khanfir K, Frascogna V, Turhan AG, Bourhis J. Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation. British Journal of Cancer. 2004 Oct 19;91(9):1735–41. doi: 10.1038/sj.bjc.6602190. |